Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study - Long, Georgina; Utikal, Jochen (Annals of oncology, 2017)
Gesehen am 30.05.2018